Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503806 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Andrea Ulloa-Fernández und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Group 3D Printing and Biofabrication, Institute of Materials Science and Technology, TU Wien, Vienna, 1060, Austria. Hauptthemen laut MEDLINE: Bioprinting, Skin Diseases, Models, Biological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020, Marie Sklodowska-Curie Actions, Federal Ministry of Economy, Energy and Tourism of Austria, National Foundation for Research, Technology, and Development of Austria to the Christian Doppler Laboratory for Chronic Inflammatory Skin Diseases.
Abstract (Originalsprache)
Chronic, non‐communicable inflammatory skin diseases, are a group of inflammatory conditions with high prevalence across the world and represent a significant challenge in medicine, due to the high number of patients arriving for medical consultations. The development of engineered skin tissue models aims to create advanced in vitro models that accurately recapitulate various skin disorders. Furthermore, the introduction of the 3Rs framework to reduce animal testing, alongside specific legislation intended to minimize such testing, has driven research toward developing in vitro models that closely imitate human conditions and skin pathologies, while also being suitable for testing new therapeutic and cosmetic products. In this context, advancements in bioprinting technologies, which promise to ensure consistent quality, reduce technical variances, and enable upscaling, can improve the reproducibility and performance of such models. This work discusses current advancements in the field of bioprinting of in vitro skin models with a particular focus on their application in the research of immune‐mediated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Group 3D Printing and Biofabrication, Institute of Materials Science and Technology, TU Wien, Vienna, 1060, Austria.
- Austrian Cluster for Tissue Regeneration, Austria.
- Department of Dermatology, Medical University of Vienna, Vienna, 1090, Austria.
- CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, 1090, Austria.
- Christian Doppler Laboratory for Chronic Inflammatory Skin Diseases, Vienna, 1090, Austria.
ORCID-Profile: Andrea Ulloa-Fernández, Marica Markovic, Julia Fernández-Pérez, Georg Stary, Aleksandr Ovsianikov
Förderung
- European Union's Horizon 2020, Marie Sklodowska-Curie Actions
- Federal Ministry of Economy, Energy and Tourism of Austria
- National Foundation for Research, Technology, and Development of Austria to the Christian Doppler Laboratory for Chronic Inflammatory Skin Diseases
Zitieren
APA
Ulloa-Fernández, A., Markovic, M., Fernández-Pérez, J., Stary, G., & Ovsianikov, A. (2026). Advances in Bioprinting to Model Immune‐Mediated Skin Diseases. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503806
Vancouver
Ulloa-Fernández A, Markovic M, Fernández-Pérez J, Stary G, Ovsianikov A. Advances in Bioprinting to Model Immune‐Mediated Skin Diseases. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503806
BibTeX
@article{UlloaFernndez2026,
author = {Ulloa-Fernández, Andrea and Markovic, Marica and Fernández-Pérez, Julia and Stary, Georg and Ovsianikov, Aleksandr},
title = {Advances in Bioprinting to Model Immune‐Mediated Skin Diseases},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503806}
}
EUVIMED